Emtricitabine and tenofovir disoproxil fumarate
- Generic Name
- Emtricitabine and tenofovir disoproxil fumarate
- Indication
适用于与其他抗逆转录病毒药物联用，治疗成人和12岁（含）以上儿童的 HIV-1感染。
Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2022-11-21
- Target Recruit Count
- 643
- Registration Number
- NCT03048422
- Locations
- 🇧🇼
Molepolole CRS, Gaborone, Botswana
🇹🇭Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, Chiang Mai, Thailand
🇿🇼St Mary's CRS, Chitungwiza, Zimbabwe
Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 30
- Registration Number
- NCT03012607
- Locations
- 🇹🇭
Sanpatong Hospital, Chiang Mai, Thailand
Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Emory University
- Target Recruit Count
- 48
- Registration Number
- NCT02985996
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Dolutegravir in Reservoirs
- First Posted Date
- 2016-10-05
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Emory University
- Target Recruit Count
- 22
- Registration Number
- NCT02924389
- Locations
- 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸Ponce De Leon Center, Atlanta, Georgia, United States
🇺🇸Emory University, Atlanta, Georgia, United States
Introducing PrEP Into HIV Combination Prevention - Kenya
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2016-04-28
- Lead Sponsor
- LVCT Health
- Target Recruit Count
- 2100
- Registration Number
- NCT02755350
- Locations
- 🇰🇪
LVCT Health, Nairobi, Kenya
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- HIV Prevention Trials Network
- Target Recruit Count
- 451
- Registration Number
- NCT02732730
- Locations
- 🇿🇼
Spilhaus CRS, Harare, Belgravia, Zimbabwe
🇿🇦Wits Reproductive Health and HIV Institute, Johannesburg, Gauteng, South Africa
🇿🇦Emavundleni CRS, Cape Town, Western Cape, South Africa
Exploratory Pharmacodynamic Study of Tenofovir-Based Products
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- CONRAD
- Target Recruit Count
- 25
- Registration Number
- NCT02722343
- Locations
- 🇺🇸
Eastern Virginia Medical School, Norfolk, Virginia, United States
Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 9
- Registration Number
- NCT02621242
- Locations
- 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- University of Missouri-Columbia
- Registration Number
- NCT02572505
- Locations
- 🇺🇸
Missouri Center for Reproductive Medicine & Fertility, Columbia, Missouri, United States
Dual Therapy With Boosted Darunavir + Dolutegravir
- Conditions
- HIV-Infection
- Interventions
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 269
- Registration Number
- NCT02486133
- Locations
- 🇩🇪
Klinikum rechts der Isar, Munich, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.